Key result
ABI detects LEAD in ~8% of cardiology patients, with physical activity linked to reduced risk.
Why the study?
Lower Extremity Artery Disease predicts atherosclerotic plaques in other locations and increases cardiovascular mortality, warranting identification of cardiology patient subpopulations that should undergo Ankle-Brachial Index measurement.
Observational (n=800)
Answers are grounded in this paper and cite their sources.
In hospitalized cardiology patients, LEAD is present in 7.6% and is strongly associated with traditional cardiovascular risk factors, suggesting targeted ABI screening may be beneficial.
Background and aims: Lower Extremity Artery Disease (LEAD) is a predictor of atherosclerotic plaques in other locations and significantly increases the risk of death from cardiovascular events. This study aimed to identify cardiology patient subpopulations that should undergo Ankle-Brachial Index (ABI) measurement. Methods: A total of 800 patients hospitalized in the Department of Cardiology were included. Inclusion criteria were age over 40 years for men and over 45 years for women, with the ability to measure ABI. Results: The study group was divided into two subgroups based on ABI values, with LEAD (ABI ≤ 0.9) detected in 61 patients (7.6%). Among these, 45% exhibited symptoms of intermittent claudication. LEAD was significantly more common in patients with a lower ejection fraction, a history of myocardial infarction, coronary artery disease, coronary atherosclerosis, heart failure, hypercholesterolemia, diabetes, and in those with a past diagnosis of atherosclerosis. There was no statistical association with the incidence of ischemic stroke, renal failure, hypertension or a family history of cardiovascular disease. Average living conditions and financial status increased LEAD likelihood (p = 0.029; p = 0.018), while physical activity reduced it (p < 0.001). LEAD occurred more often in both current and former smokers. Patients with LEAD were more likely to be on statin therapy (p = 0.002). Higher hemoglobin A1c levels significantly increased the risk of LEAD. Conclusions: Identifying patients with risk factors for LEAD suggests that ABI measurement should be performed to detect LEAD early and implement appropriate diagnostic and therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Zambrzycki et al. (2024) conducted an observational in Lower Extremity Artery Disease (LEAD) (n=800). Ankle-Brachial Index (ABI) measurement was evaluated on Detection of LEAD (ABI ≤ 0.9). Ankle-Brachial Index measurement detected Lower Extremity Artery Disease in 7.6% of cardiology patients, with physical activity reducing its likelihood.
Synapse has enriched 10 related papers. Consider them for comparative context: